As a branch of medicine, personalized medicine includes every element of a patient’s healthcare. For instance, by examining a patient’s records, a more specific treatment method can be established. The genetic testing industry is expected to mark an average annual increase of 12.4% by 2030. The core of personalized medicine is eliminating the trial-and-error prescription of drugs and implementing evidence-based practices, made possible by modern pharmacogenomics.
Genetic Testing: Advancing Personalized Treatment in Medicine
This is a very good example of how the need of an increasingly competitive industry leads to the development of technologies that aim to pinpoint a person’s requirements. Genetic testing is one such technology that is used by doctors to develop specific treatment plans when modified medication plans are required. It makes it possible to utilize a person’s DNA profile and acquire pertinent information relative to the person’s genetic constitution, enabling the physician to determine the best-fit medications for the patient. Hence, it becomes possible to prescribe the most appropriate drugs with maximum compliance and minimum adverse reactions. An excellent example is in pharmacogenomics, where these genetically informed clinicians are able to prescribe effective, safe doses without wasting resources.
Custom Drug Solutions and Genomic Information
Drug therapy enhancement leans on the integration of medicine with genetics; this has been precision medicine's stronghold. There are genetic characteristics that determine the effectiveness and side effects of particular drugs on a specific patient. For example, CYP2C19 genetic polymorphisms influence the disposition of some drugs, including clopidogrel, a widely used blood-thinning drug. With the help of genetic tests that physicians are now able to get, they can modify their patient’s drug prescription to meet their genetic make-up physiologically, thereby improving treatment outcomes.
